Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02876159 · ClinicalTrials.gov registry record · Phase 4
The Immunologic Basis for an Attenuated Immune Response to the Influenza Vaccine After Repeated Annual Vaccination
A Phase 4 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT02876159 is a Phase 4 study that has completed, run by Emory University. The registered enrollment target is 20 participants.
The verdict
NCT02876159, a Phase 4 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
This is a prospective pilot study designed to suggest differences in the immunologic response to the seasonal influenza vaccine in people with regular vaccination history compared to those vaccinated less regularly. Participants will receive one dose of the Food and Drug Administration (FDA) approved 2016-2017 seasonal influenza vaccine. Immune system data will be collected at standard time points. The duration of the study for each participant will be approximately 1 month.
Interventions
- BIOLOGICAL 2016-2017 Influenza Vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2016-07 |
| Est. Completion | 2016-12-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02876159
The ClinicalTrials.gov registry entry for NCT02876159 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 2016-2017 Influenza Vaccine is the first listed.
NCT02876159 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02876159 about?
NCT02876159 is a clinical study titled "The Immunologic Basis for an Attenuated Immune Response to the Influenza Vaccine After Repeated Annual Vaccination". This is a prospective pilot study designed to suggest differences in the immunologic response to the seasonal influenza vaccine in people with regular vaccination history compared to those vaccinated less regularly. Participants will receive one dose of the Food and Drug Administration (FDA) approve...
What is the current status of trial NCT02876159?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2016-07. Estimated completion is 2016-12-01.
What interventions are being tested in trial NCT02876159?
The interventions under investigation include: 2016-2017 Influenza Vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT02876159?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.